The diagnosis of urinary tract infection (UTI) is confirmed by urine testing with urinalysis and culture. No study has characterized the use of urine testing in the setting of empirical antibiotic prescription for outpatient UTI in children.
Despite the fact that urinalysis and culture are recommended in all children aged 2 to 24 months suspected of having urinary tract infection (UTI), 1, 2 previous research has shown that practitioners are often more selective with urine testing than guidelines suggest. 3 Moreover, there are no USpromulgated guidelines for the pediatric patient aged .2 years; European guidelines offer the option for more selective testing, with urinalysis alone, in a child aged .3 years with low risk of serious illness and no history of UTI. 1 No guidelines endorse empirically prescribing antibiotics without conducting either urinalysis or culture.
The goals of the current study were to characterize trends in urine testing and factors associated with utilization of urine cultures when empiric antibiotics are prescribed for presumed UTI in children in the outpatient setting.
METHODS
Institutional review board approval was granted at participating institutions.
Study Design and Data Source
We retrospectively evaluated urine test utilization for children aged ,18 years who were prescribed antibiotics for UTI during the period 2002 through 2007. We analyzed data from Innovus i3, a private claims database that collects United Healthcare insurance enrollment information and submitted medical and prescription reimbursement claims from ∼39 million insured individuals and their dependents from all 50 states. Available data include patient demographics such as age and gender, as well as procedure and diagnosis codes, dates of service, and information regarding the treatment facility and provider. Reimbursement claims for completed laboratories and filled prescriptions are recorded. The prescription claims consist of prescription fill date, refills, brand name, and therapeutic class.
Study Population
The study population comprised patients ,18 years of age who had an outpatient visit with a primary diagnosis of UTI (International Classification of Diseases, Ninth Revision [ICD-9] codes 595.0, 595.2, 593.3, 595.81, 595.89, 595.9, 5980.03, 590.13, 590.2, 590.3, 590.80, 599.0, and 771.8) and had an antibiotic prescribed within 3 days before, and 5 days after the UTI visit (Fig 1) . Patients with UTI as a secondary diagnosis were included if fever (780.6) or dysuria (788.1) was the primary diagnosis. We allowed the date of antibiotic prescription to precede the UTI visit date because patients may initially be prescribed antibiotics after phone consultation and subsequently followup in the clinical setting. Antibiotic prescriptions for UTI were limited to those prescriptions with ,30-days' supply to exclude prescriptions written for antibiotic prophylaxis. Visits were excluded in which patients were diagnosed with a UTI and another infection for which antibiotics are commonly prescribed to ensure that UTI was the primary reason for the visit and resulting antibiotic prescription. 4, 5 To capture comorbidities and recurrent UTI events more accurately, eligible subjects were required to have 1 year of follow-up after the first UTI visit and either 1 year of enrollment before the UTI visit or coverage since birth.
FIGURE 1
Study population: pediatric antibiotic-treated UTI episodes. A UTI episode includes the 14-day period after initial visit date of the UTI. One patient may have multiple UTI episodes, and therefore, the total number of episodes (40 603) is greater than the total number of patients (28 678) in the study. 
Antibiotic Classification
Antibiotics were categorized based on codes from the National Drug Code Directory and the American Hospital Formulary Service. 6, 7 We included the following antibiotic categories: penicillins cephalosporins, sulfonamides (trimethoprims and sulfonamides), urinary anti-infective agents (nitrofurantoins and methenamine mandelates), aminoglycosides, tetracyclines, macrolides, quinolones, lincosamides, and carbepenems. Broad-spectrum antibiotics were defined as broadspectrum penicillins (antipseudomonal penicillins and b-lactamase/b-lactam inhibitor combination penicillins); second-, third-, or fourth-generation cephalosporins; macrolides; quinolones; lincosamides; and carbapenems. Drug formulations not applicable to UTI treatment, such as topical formulations, were excluded. Pharmacy claims were used to capture oral antibiotic prescriptions. Parenteral antibiotic administration was captured by J code classification from the Healthcare Common Procedure Coding System, which is used to report injectable drugs. 8 
Definitions and Measurements
A UTI episode was defined as the 14-day period after the initial visit date of the UTI. A recurrent UTI was defined as a visit for UTI occurring after the 14-day window of the preceding UTI. If multiple antibiotics were prescribed during a UTI episode, the first antibiotic prescribed during the episode was defined as the empirically prescribed antibiotic. Urine testing was captured by current procedural terminology codes (Urinalysis: 81000, 81001, 81002, 81003, 81004, 81005, 81007, and 81015; Urine Culture: 87086, 87088, 87181, 87184, 87185, 87186, and 87188). We defined urine test use associated with empiric antibiotic prescription as a urine test that occurred within 3 days before or after the first antibiotic prescribed in a UTI episode. We used an extended window of time to capture claims for urine testing to ensure testing was not overlooked due to delay in claims processing. Because providers may be more likely to perform urine testing based on patient age and likelihood for UTI, age was partitioned into categories: ,2 years, 2 to 5 years, 6 to 12 years, and 13 to 17 years. 4 Geographic region was based on US Census definitions of Northeast, Midwest, South, and West. Physician specialty was divided into 5 main categories: family/internal medicine, pediatrics, emergency medicine, urology, and other.
We identified patients with complex, chronic medical conditions by using the ICD-9 codes previously proposed by Feudtner et al. 9 We assessed for the presence of the following conditions because of their association with an increased risk for resistant UTI: history of previous UTI, recent antibiotic exposure, recent hospitalization, and presence of genitourinary anomaly. [10] [11] [12] Recent antibiotic exposure was classified as an antibiotic prescribed within 30 days before the UTI visit date. Recent hospitalization was defined as hospitalization within 30 days before UTI visit date. The presence of a urologic anomaly was defined by ICD-9 codes for the following conditions: hydronephrosis, renal/ureteral stones, vesicoureteral reflux, bladder stone, neurogenic bladder, ureteropelvic junction obstruction/other obstruction, ureterovesical junction obstruction, ureterocele, posterior urethral valves, ectopic ureter/other ureteral anomalies, spina bifida, and bladder exstrophy.
Statistical Analysis
Summary statistics were performed by using frequencies and proportions for categorical variables. Unadjusted associations were tested between predictor variables and the outcome variable (urine culture utilization with empirical antibiotic prescription) by using the x 2 test. We evaluated trends in urine test utilization and performed multivariable logistic regression to identify demographic and clinical factors associated with urine culture utilization with antibiotic-treated UTI. The unit of analysis for bivariate and multivariable analyses was a "UTI episode." In the multivariable modeling, we clustered at the patient level to account for multiple observations in some patients who had recurrent UTI. Covariates with P , .2 on univariate analysis were included in the final model. We performed a stratified multivariable analysis by age ,13 years and age 13 to 17 years because providers may be more likely to perform urine testing based on the age of the patient and likelihood for UTI. All analyses were 2-sided; we established P , .05 as statistically significant.
RESULTS

Patient Population
There were 40 603 antibiotic-treated UTI episodes among the 28 678 patients from 2002 through 2007 (Table 1 ). The majority of the UTI episodes occurred in females (90%). Approximately 16% of the UTI episodes occurred in patients who had a urologic anomaly, and ,2% occurred in patients with other nonurologic comorbidities. Twenty-nine percent of UTI episodes were recurrent UTIs.
Antibiotic Prescription and Urine Testing
Empiric antibiotics were broad-spectrum in 29% of the total antibiotic-treated UTI episodes (11 652 of 40 603). Urinalysis was performed in 76% and urine culture was performed in 57% of the total UTI episodes, respectively ( period from 60% to 54% (P , .0001). Urine testing (either urinalysis or culture) was performed in ∼80% of UTI episodes. The lowest percentage of urine testing among UTI episodes occurred in children ,2 years at 68% compared with all other age groups and urine testing in this age group also declined during the study period (69% to 65%, P , .001). The majority of UTI episodes were treated by pediatricians (46%) and family/internal medicine physicians (27%). Emergency department physicians (10%) and urologists (2%) treated a smaller percentage of UTI episodes (Table 3) .
Factors Associated With Urine Culture Use in Antibiotic-treated UTI See were independent predictors of urine culture utilization. Children were less likely to have urine cultures performed if they were male (OR 0.8, 95% CI 0.8-0.9), treated by a urologist (OR 0.5, 95% CI 0.4-0.6), lived in the Northeast (OR 0.9, 95% CI 0.8-0.9) or West (OR 0.8, 95% CI 0.8-0.9) compared with the South, or were hospitalized within the past 30 days (OR 0.5, 95% CI 0.5-0.6). Previous UTI, urologic anomalies, and nonurologic comorbidities were not associated with urine culture utilization. We found analogous results on agestratified analysis (,13 years and 13-17 years), with no substantial changes in magnitude or direction of adjusted ORs compared with the overall model.
DISCUSSION
To our knowledge, this is the first largescale, claims-based study in children evaluating practice patterns surrounding urine testing in antibiotictreated UTIs. Our study had 3 major findings: (1) urine tests are not performed in a substantial percentage of antibiotic-treated UTI episodes, (2) there was considerable variation in urine culture utilization among different groups of patients and physicians, and (3) factors that place a patient at increased risk for resistant UTI (history of previous UTI, recent antibiotic exposure, recent hospitalization, and presence of genitourinary anomaly) [10] [11] [12] were not strongly associated with urine culture use.
We found not only that urine cultures were performed in ,60% of antibiotictreated UTI episodes, but also that in ∼20% of antibiotic-treated UTI episodes no urine testing (urinalysis or urine culture) was done. The question 15 One clear benefit to this approach is cost savings and previous research demonstrated that such a treatment algorithm in the adult female population does not increase adverse outcomes. 16 Although comparable pediatric literature is lacking, the National Institute for Health and Clinical Excellence guidelines recommend urinalysis alone to establish the diagnosis and initiate treatment of a standard UTI in a child .3 years.
That said, there are implications associated with treating a presumed UTI without culture confirmation in the pediatric population. First, patients are frequently referred to specialists for UTI evaluation and management even though they have never had a UTI confirmed by urinalysis or culture. 17 Specifically, toilet-trained children with bladder and bowel dysfunction can exhibit signs and symptoms similar to UTI but often do not have infection. 18 Improperly labeling a child with a UTI can lead to unnecessary testing, which may be traumatic, may expose the child to needless radiation, and may potentially incite infection. 19, 20 An additional issue is that lack of culture-proven UTI may delay evaluation for the presence of concomitant urologic abnormality until symptoms recur and cultures are obtained. This argument is heavily debated and contingent on the ability of intervention for the urologic abnormality to reduce reinfection and its long-term sequelae. [21] [22] [23] When urine cultures were performed in antibiotic-treated UTIs, we identified considerable variability in utilization among different groups of patients and physicians. We did not observe an association with urine culture utilization in children ,2 years despite the fact that children this age cannot effectively communicate and often present with nonspecific symptoms that the majority of the time are attributable to an etiology other than UTI. Moreover, we observed that males had decreased odds of urine culture utilization with similar results on age-stratified analysis despite the fact that males, in general, are less likely to have a UTI compared with females. 24 However, circumcision status was unknown, and because being uncircumcised can be a risk factor for UTI, it may influence a provider' s decision to obtain a culture. Conversely, patients who were prescribed empiric broad-spectrum antibiotic treatment were more likely to have a urine culture performed. These may be patients for whom the prescribing physician has concern for a resistant uropathogen; therefore, it would be important to obtain a urine culture to tailor empiric therapy.
In addition, the odds of urine culture utilization varied significantly by provider type, with pediatricians most likely to obtain urine cultures, followed by emergency department physicians. Pediatricians may be more likely to obtain urine cultures compared with other physicians due to familiarity with the current US guidelines on urine testing that are generated by a pediatricianbased organization, the American Academy of Pediatrics. In contrast, urologists had 50% lower odds of obtaining a urine culture. This finding is unanticipated, given that urologists are more likely to manage patients with urologic abnormalities, and research shows that these patients are at greater risk for resistant UTI. 10 We also saw variation in utilization based on region.
Although resistance patterns are known to vary at the regional level, the size of the regions evaluated in our study were likely too broad to identify differences based on regional resistance patterns. Therefore, the observed discrepancies in practice patterns might be influenced by nonclinical factors.
Previous research supports that history of UTI, presence of genitourinary anomaly, recent antibiotic exposure, and recent hospitalization are associated with an increased risk for resistant UTI. [10] [11] [12] It is indicated to perform urine cultures in patients with these risk factors so that treatment of UTIs that prove to be resistant to empiric antibiotic therapy can be appropriately tailored. Nonetheless, we found no association with urine culture utilization in patients with previous UTI or genitourinary anomaly, only a weak association in patients with previous antibiotic exposure, and decreased odds of utilization in patients who had been recently hospitalized. Given that the current study is a retrospective claims analysis, one explanation for these findings is that past medical history was not elicited by the treating physician and therefore not considered in the decision-making. Also, recent antibiotic exposure may have been weakly associated with urine culture use because there may not have been widespread awareness that it was a risk factor for resistant UTI. Few studies had been published regarding previous antibiotic exposure and risk of resistant UTI in the pediatric literature previous to the study period. 10, 25, 26 Finally, it is unclear as to why children who were recently hospitalized had a lower odds of being cultured. Conceivably, if a urine culture was collected during recent hospital admission, the physician may have decided not to repeat the culture. However, if the child was well enough to be discharged and then re-presented in the ambulatory setting with UTI, cultures performed during the admission might not accurately reflect the present infection.
Our study should be interpreted with limitations in mind. First, the lack of distinction between coding for "ruleout UTI" and actual UTI may explain why a large proportion of patients with a UTI ICD-9 code did not receive antibiotics. Most UTI patients without an antibiotic prescription had urine testing (71%), which likely represents patients evaluated for rule-out UTI who were not prescribed antibiotics because of negative urine testing. The remaining 29% of UTI patients who were not prescribed antibiotics and had no urine testing may represent patients with a remote UTI history, ruleout UTI visits without urine testing, and coding inaccuracies. However, our study population likely consists of patients with true UTI because we based patient selection on a combination of UTI ICD-9 code, antibiotic prescription, and lack of concomitant infection. Also, antibiotic prescription and urine testing information is likely robust because it is generated by submitted insurance claims from pharmacies and laboratories, respectively. Second, the claims database analyzed for this study represents a select population that is privately insured and does not include Medicaid or those without insurance. Consequently, these results may not apply to all children. Third, the database does not include certain demographic and clinical information that allows assessment of the appropriateness of urine test utilization. 3, 27 For example, we were unable to account for factors that affect the likelihood for UTI and may influence a provider' s decision to obtain a urine test such as race, circumcision status, and presence of lower urinary tract symptoms or fever. Finally, there is a risk for underestimating urine test utilization by incompletely capturing all urine studies performed. To minimize this, we used an extended window of time before and after antibiotic prescription to ensure maximum capture of urine testing claims. Also, some urine testing done by dipstick in the clinical setting may not have been captured because it requires that the provider bill for this test. The remaining urine studies would be captured with a claims analysis because formal laboratory testing is required for microscopic urinalysis and culture.
CONCLUSIONS
Our findings reveal that antibiotics are empirically prescribed for a significant number of UTI episodes without urine testing. There may be clinical situations and populations of children in which this practice is appropriate; however, additional research is necessary to determine whether thisapproachissafeandeffective.
CYCLING ON GRAVEL: I live in a small Vermont town. Like most small towns in Vermont, more roads are dirt or gravel than paved. While for many, this would be a cause for concern, for me the gravel roads are wonderful and perfect for cycling. There are few cars, the cars that are around have to drive a bit slower, and you can hear them approaching. While I cycle for exercise, the rides in my area are beautiful and made for enjoyment. A quick 25 mile ride brings beautiful views of hills, farms, and vistas of the lake and mountains. While I thought I liked gravel biking more than most, The New York Times (Sports: June 11, 2013) reports that entire road races are held on gravel roads. Called gravel grinding, riders will race 100-200 miles over rural gravel roads in Kansas, Minnesota, or Iowa. Gravel events are quite different from most other races. For one, most are free or associated with a nominal fee. Second, riders receive little assistance. In most races, they can only receive help at designated checkpoints 50 miles apart. Prizes are simple, such as a belt buckle or bike parts donated by race sponsors. The goal primarily is to test oneself and enjoy the experience and views. While I am not sure I am ready yet for a 200 mile gravel race, I think that I may have to try one of the shorter races. I am quite curious how my trusty bike and I will do. It should be fun.
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